Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Caribou Biosciences (CRBU) Non Operating Income: 2019-2024

Historic Non Operating Income for Caribou Biosciences (CRBU) over the last 6 years, with Dec 2024 value amounting to $17.5 million.

  • Caribou Biosciences' Non Operating Income fell 47.89% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year decrease of 90.55%. This contributed to the annual value of $17.5 million for FY2024, which is 23.41% up from last year.
  • As of FY2024, Caribou Biosciences' Non Operating Income stood at $17.5 million, which was up 23.41% from $14.2 million recorded in FY2023.
  • In the past 5 years, Caribou Biosciences' Non Operating Income registered a high of $17.5 million during FY2024, and its lowest value of -$3,000 during FY2020.
  • In the last 3 years, Caribou Biosciences' Non Operating Income had a median value of $14.2 million in 2023 and averaged $12.9 million.
  • Per our database at Business Quant, Caribou Biosciences' Non Operating Income crashed by 100.09% in 2020 and then soared by 12,666.67% in 2021.
  • Caribou Biosciences' Non Operating Income (Yearly) stood at -$3,000 in 2020, then skyrocketed by 12,666.67% to $377,000 in 2021, then spiked by 1,769.50% to $7.0 million in 2022, then surged by 101.22% to $14.2 million in 2023, then climbed by 23.41% to $17.5 million in 2024.